These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10370715)

  • 1. Treatment of diseases of the central nervous system using encapsulated cells.
    Hottinger AF; Aebischer P
    Adv Tech Stand Neurosurg; 1999; 25():3-20. PubMed ID: 10370715
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical perspectives of xenografts: encapsulated chromaffin cells and pain].
    Bès JC; Lazorthes Y; Sol JC; Tkaczuk J; Sallerin B
    Pathol Biol (Paris); 2000 May; 48(4):365-7. PubMed ID: 10868399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve growth factor delivery systems.
    Haller MF; Saltzman WM
    J Control Release; 1998 Apr; 53(1-3):1-6. PubMed ID: 9741908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of encapsulated cell technologies as therapies for neurological and sensory diseases.
    Zanin MP; Pettingill LN; Harvey AR; Emerich DF; Thanos CG; Shepherd RK
    J Control Release; 2012 May; 160(1):3-13. PubMed ID: 22285549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain.
    Joseph JM; Goddard MB; Mills J; Padrun V; Zurn A; Zielinski B; Favre J; Gardaz JP; Mosimann F; Sagen J
    Cell Transplant; 1994; 3(5):355-64. PubMed ID: 7530113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited commentary: treatment of diseases of the central nervous system using encapsulated cells, by A. F. Hottinger and P. Aebischer (Advances and Technical Standards in Neurosurgery vol. 25).
    Rosser AE; Ostenfeld T; Svendsen CN
    Adv Tech Stand Neurosurg; 2000; 26():125-8. PubMed ID: 10997199
    [No Abstract]   [Full Text] [Related]  

  • 7. Viability and functionality of bovine chromaffin cells encapsulated into alginate-PLL microcapsules with a liquefied inner core.
    Moustafa T; Girod S; Tortosa F; Li R; Sol JC; Rodriguez F; Bastide R; Lazorthes Y; Sallerin B
    Cell Transplant; 2006; 15(2):121-33. PubMed ID: 16719046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells.
    Date I; Shingo T; Ohmoto T; Emerich DF
    Exp Neurol; 1997 Sep; 147(1):10-7. PubMed ID: 9294398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotrophin delivery using nanotechnology.
    Angelova A; Angelov B; Drechsler M; Lesieur S
    Drug Discov Today; 2013 Dec; 18(23-24):1263-71. PubMed ID: 23891881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience.
    Buchser E; Goddard M; Heyd B; Joseph JM; Favre J; de Tribolet N; Lysaght M; Aebischer P
    Anesthesiology; 1996 Nov; 85(5):1005-12; discussion 29A-30A. PubMed ID: 8916816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophic factors and neurodegenerative diseases: a delivery issue.
    Ruozi B; Belletti D; Bondioli L; De Vita A; Forni F; Vandelli MA; Tosi G
    Int Rev Neurobiol; 2012; 102():207-47. PubMed ID: 22748832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human fetal astrocytes as an ex vivo gene therapy vehicle for delivering biologically active nerve growth factor.
    Lin Q; Cunningham LA; Epstein LG; Pechan PA; Short MP; Fleet C; Bohn MC
    Hum Gene Ther; 1997 Feb; 8(3):331-9. PubMed ID: 9048200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentials of ES cell therapy in neurodegenerative diseases.
    Srivastava AS; Malhotra R; Sharp J; Berggren T
    Curr Pharm Des; 2008; 14(36):3873-9. PubMed ID: 19128238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuronal growth factors--neurotrophins].
    Meyer M; Rasmussen JZ
    Ugeskr Laeger; 1999 Apr; 161(14):2063-70. PubMed ID: 10354791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration.
    Skaper SD; Walsh FS
    Mol Cell Neurosci; 1998 Nov; 12(4-5):179-93. PubMed ID: 9828084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomaterials for Enhancing CNS Repair.
    Lim TC; Spector M
    Transl Stroke Res; 2017 Feb; 8(1):57-64. PubMed ID: 27251413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum.
    Emerich DF; Hammang JP; Baetge EE; Winn SR
    Exp Neurol; 1994 Nov; 130(1):141-50. PubMed ID: 7821389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation.
    Baby N; Patnala R; Ling EA; Dheen ST
    Curr Med Chem; 2014; 21(37):4215-26. PubMed ID: 25039775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell encapsulation for the treatment of central nervous system disorders].
    Portero A; Orive G; Hernández RM; Pedraz JL
    Rev Neurol; 2010 Apr; 50(7):409-19. PubMed ID: 20387211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophic factors in neurodegenerative disorders : potential for therapy.
    Fumagalli F; Molteni R; Calabrese F; Maj PF; Racagni G; Riva MA
    CNS Drugs; 2008; 22(12):1005-19. PubMed ID: 18998739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.